HONEYWELL, JOHNSON MATTHEY, GIDARA ENERGY AND SAMSUNG E&A FORM SAF TECHNOLOGY ALLIANCE
Industry leaders form groundbreaking alliance to help drive the end-to-end production of SAF from biomass and municipal waste Joint technology offering leverages... Read more.
Bybit donates over $300,000 to support earthquake relief in Myanmar and Thailand
DUBAI, UAE, June 5, 2025 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, has pledged over $300,000 to support... Read more.
Tsingke Biotech Participates in TIDES USA 2025, Demonstrates Full-Scale Oligonucleotide Synthesis Capabilities
BEIJING, June 4, 2025 /PRNewswire/ — Tsingke Biotech recently participated in TIDES USA 2025, the leading international event for oligonucleotide and peptide... Read more.
Preliminary Data from Two Clinical Trials with ADC Candidates were Presented Orally at the 2025 ASCO Annual Meeting
SHANGHAI and CHICAGO, June 4, 2025 /PRNewswire/ — The 2025 ASCO Annual Meeting is taking place in Chicago, US, from May 30 to June 3. Duality Bio (HKEX: 9606.HK)... Read more.
The Canadian Space Agency remembers Marc Garneau
LONGUEUIL, QC, June 4, 2025 /CNW/ – Former Canadian Space Agency (CSA) astronaut Marc Garneau has passed away at the age of 76. Garneau was one of the original... Read more.
Envision Energy Partners with SUN Terra to Build Full-Chain Energy Storage Ecosystem
SHANGHAI, June 4, 2025 /PRNewswire/ — Envision Energy, a global leader in green technology, announced a strategic partnership with SUN Terra, Indonesia’s... Read more.
Ganzin Unveils Gaze2AI™ Reference Design at AWE 2025: Redefining the Human-AI Interface with 3D Gaze Technology
TAIPEI CITY, June 4, 2025 /PRNewswire/ — Ganzin Technology, a leading innovator in wearable eye-tracking solutions, proudly announces the launch of its groundbreaking... Read more.
Volition Announces Two Oral Presentations at Asian Meeting of Animal Medicine Specialties
HENDERSON, Nevada, June 4, 2025 /PRNewswire/ — VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”), a multi-national epigenetics company, today... Read more.
Innovent’s IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) Receives Second NMPA Breakthrough Therapy Designation for Immuno-resistant Squamous Non-Small Cell Lung Cancer
SAN FRANCISCO and SUZHOU, China, June 4, 2025 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical... Read more.
Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Renal Cell Carcinoma
SAN FRANCISCO and SUZHOU, China, June 4, 2025 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical... Read more.